My Doctor in Western Massachusetts started me on this and I am waiting for my first month supply to come in ten days.
I gave myself a shot of
Thymosin-alpha-1 in the Doctor's office and I drove 3 and half hours back home to Northeastern Vermont, a trip that usually leaves me exhausted. I really can not believe how good this Peptide made me feel. I ordered a month supply (taking injection every third day) for about $400.00 a month which is $50.00 a shot. Here is some information:
Professional Monograph Thymosin alpha 1 INDICATION and USAGE SUMMARY
● Thymosin alpha-1 is a synthetic thymic peptide ● Modulates innate immunity (pleiotropic) , , 1 2 3 o
Improves Th1 immune responses and helps balance Th1/Th2 o
Promotes T cell (Tregs) differentiation and maturation o
Decreases T-cell apoptosis o Improves CD3+, CD4+ and CD8+ o Improves production of IL-1 beta, IFN-γ, IL-2, IL-3, IL-6, IL-10 o Improves NK cell activity and TNF-alpha o Improves macrophages and B cells o Up regulates MHC Class I expression in antigen expressing cell o Tumor specific antigens; anti-tumor properties o Inhibits viral replication o Activates indoleamine 2,3-dioxygenase enzyme - dampens immunity o Improves dendritic cell tryptophan catabolism
●
Antioxidant properties – improves intracellular glutathione 1 Garaco E, Pica F, Serafino A, et al. Thymosin alpha-1 and cancer: action on immune effector and tumor target cells. Ann NY Acad Sci. 2012;1269:26-33. 2 Romani L, MorettiS, Fallarino F, et al. Jack of all trades: thymosin alpha-1 and its pleiotropy. Ann NY Acad Sci. 2012;1269:1-6. 3 Romani L, Bistoni F, Perruccio K, et al. Thymosin alpha 1 activates dendritic cell tryptophan catabolism and estraclishes a regulatory environment for balance of inflammation and tolerance. Blood. 2006;108(7):2265-74. © Copyright 2018, Scientific Performance Research, LLC" Cincinnati, OH
●
Used for clinical conditions where immune support is necessary o Conditions requiring immune response modulation o Hepatitis B & C o HIV/AIDS o Cancer – non-small cell lung (NSCLC), hepatocellular, malignant melanoma o Chemotherapy adjunct o Chronic inflammatory conditions; autoimmunity o Cystic fibrosis o Lyme disease o Blocks steroid-induced apoptosis of thymocytes o Depressed response to vaccinations; adjunct to flu vaccine o Geriatric immune support o DiGeorge’s syndrome
●
May reduce hematological toxicity of cytotoxic drug therapies o Cyclophosphamide o 5-fluorouracil (5FU) o Dacarbazine o Ifosfamide
●
Zadaxin™ – proprietary thymosin alpha 1 (thymalfasin) approved in 30 countries for hepatitis B and C and cancer. , 4 5 o Phase II clinical trials US – Hepatitis B o Phase III clinical trials US – Hepatitis C o Indicated as a monotherapy or combination therapy with interferon for the treatment of chronic hepatitis B, hepatitis C and cancer. 6 o Also indicated for treatment of non-small cell lung cancer (NSCLC), hepatocellular carcinoma, AIDS and malignant melanoma. , 7 8 o General dosage ▪ 1.6 mg, injected SubQ, 2 times weekly for 6-12 months ▪ Patients weighing < 40 kg, dosage adjusted to 40 mcg/kg, 2 times weekly. o May be used together with conventional antiretroviral regimens o Individual dosage requirements may vary based on clinical presentation Name(s): Thymosin alpha-1, thymalfasin, Zadaxin™ Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-LysLys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH Molecular formula: C129H215N33O55 Molar Weight: 3108.28 g/mol D
also please find link below to
Madison Area Lyme Support Group for an in depth article about Peptides.
https://madisonarealymesupportgroup...volutionize-the-future-of-precision-medicine/
Good Luck Everyone I will keep you posted.
Michael
